Patents by Inventor Andrew James Bird

Andrew James Bird has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
    Patent number: 6531511
    Abstract: The use of a compound of formula (1), as disclosed in the specification, wherein R1, R2, R3, R4, R5 and R6 are independently selected from hydrogen, alkyl and aryl, or pharmaceutically acceptable salts thereof, with the proviso that wherein R1 to R4 and R6 are hydrogen, R5 is not selected from CH2CH2NHSO2CH3, CH2CH2NHSO2CF3 and methyl substituted by SO2NH2, SO3H, PO3H2, CONHOH or a heterocyclic group selected from formulae (a), (b), (c), (d) and (e) in the manufacture of a medicament for use in the treatment of a condition generally associated with abnormalities in glutamatergic transmission.
    Type: Grant
    Filed: October 16, 2001
    Date of Patent: March 11, 2003
    Assignee: Vernalis Research Limited
    Inventors: Roger John Gillespie, Nathaniel Julius Thomas Monck, Andrew James Bird, Simon Edward Ward
  • Adamantanecarboximidamide derivatives and their use as NMDA antagonists
    Patent number: 6262106
    Abstract: The compound of the above formula wherein R1-R5 are independently selected from hydrogen, alkyl and aryl and prodrugs thereof; and pharmaceutically acceptable salts thereof; and use of the compounds in therapy, particularly for treatment of a condition generally associated with abnormalities in glutamtergic transmission.
    Type: Grant
    Filed: September 13, 2000
    Date of Patent: July 17, 2001
    Assignee: Vernalis Research Limited
    Inventors: Nathaniel Julius Thomas Monck, Roger John Gillespie, Andrew James Bird